FERMT2 and prostate cancer: Kindlin-2 has been shown to be expressed in malignant mesothelioma and regulates adhesion and migration [10], and the expression level of Kindlin-2 is related to the sensitivity of prostate cancer cells to cisplatin-induced cell death [11].